Filing Details
- Accession Number:
- 0001209191-20-030487
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-19 16:31:31
- Reporting Period:
- 2020-05-15
- Accepted Time:
- 2020-05-19 16:31:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1446372 | M Paul Silva | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp & Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-05-15 | 10 | $275.71 | 15,073 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 30 | $279.89 | 15,043 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 20 | $281.81 | 15,023 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 10 | $282.85 | 15,013 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 20 | $285.51 | 14,993 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 14 | $287.00 | 14,979 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 47 | $288.04 | 14,932 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 169 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $279.89 (range $279.42 to $280.19).
- Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $281.81 (range $281.62 to $282.00).
- Open market sales reported on this line occurred at a weighted average price of $285.51 (range $285.37 to $285.64).
- Open market sales reported on this line occurred at a weighted average price of $287.00 (range $286.76 to $287.75).
- Open market sales reported on this line occurred at a weighted average price of $288.04 (range $287.77 to $288.47).
Billionaire Hedge Funds
